Innova Captab Limited (INNOVACAP.NS)
INR 854.8
(2.47%)
INR 854.8
(2.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.2 Billion INR | 29.66% |
| 2022 | 10.18 Billion INR | 77.02% |
| 2021 | 5.75 Billion INR | 55.7% |
| 2020 | 3.69 Billion INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 11.73 Billion INR | 8.04% |
| 2023 FY | 13.2 Billion INR | 29.66% |
| 2023 Q4 | 13.2 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 10.86 Billion INR | 6.62% |
| 2022 Q4 | 10.18 Billion INR | 0.0% |
| 2022 FY | 10.18 Billion INR | 77.02% |
| 2021 FY | 5.75 Billion INR | 55.7% |
| 2020 FY | 3.69 Billion INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 45.695% |
| Albert David Limited | 4.97 Billion INR | -165.242% |
| Alembic Limited | 23.28 Billion INR | 43.28% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -2705.449% |
| Hester Biosciences Limited | 6.62 Billion INR | -99.424% |
| Hikal Limited | 24.87 Billion INR | 46.892% |
| Ind-Swift Limited | 6.54 Billion INR | -101.824% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -450.226% |
| Unichem Laboratories Limited | 31.69 Billion INR | 58.323% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 79.507% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -794.411% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -72.635% |
| Brooks Laboratories Limited | 904.45 Million INR | -1360.418% |
| Eris Lifesciences Limited | 70.48 Billion INR | 81.261% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 43.711% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -508.482% |
| Wanbury Limited | 3.43 Billion INR | -284.544% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 48.845% |
| Alkem Laboratories Limited | 155.74 Billion INR | 91.519% |
| FDC Limited | 24.68 Billion INR | 46.482% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 53.66% |
| Gufic Biosciences Limited | 10.92 Billion INR | -20.9% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -13.37% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 41.148% |
| Ipca Laboratories Limited | 111.01 Billion INR | 88.102% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 88.562% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -88.619% |
| Lupin Limited | 239.97 Billion INR | 94.496% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -296.156% |
| Medico Remedies Limited | 961.95 Million INR | -1273.124% |
| Morepen Laboratories Limited | 12.93 Billion INR | -2.14% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 39.715% |
| Orchid Pharma Limited | 15.53 Billion INR | 14.994% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -66.282% |
| RPG Life Sciences Limited | 5.12 Billion INR | -157.547% |
| Sigachi Industries Limited | 6.94 Billion INR | -90.286% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 98.454% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 41.401% |
| Themis Medicare Limited | 5.66 Billion INR | -133.2% |
| Vaishali Pharma Limited | 799.55 Million INR | -1552.016% |
| Venus Remedies Limited | 6.26 Billion INR | -110.724% |
| Windlas Biotech Limited | 6.26 Billion INR | -110.934% |
| ZIM Laboratories Limited | 4.46 Billion INR | -195.617% |
| Sakar Healthcare Limited | 3.88 Billion INR | -239.856% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 97.069% |
| Divi's Laboratories Limited | 154.7 Billion INR | 91.462% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -22.527% |
| Mankind Pharma Limited | 119.63 Billion INR | 88.959% |
| Sequent Scientific Limited | 15.4 Billion INR | 14.25% |
| Laurus Labs Limited | 83.87 Billion INR | 84.251% |
| Neuland Laboratories Limited | 18.32 Billion INR | 27.922% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 66.929% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 90.801% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 95.489% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -260.04% |
| Wockhardt Limited | 76.49 Billion INR | 82.731% |
| Bal Pharma Limited | 3.2 Billion INR | -312.274% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 96.591% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -8.816% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -1199.938% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 51.031% |
| Shilpa Medicare Limited | 30.93 Billion INR | 57.297% |
| Valiant Laboratories Limited | 3.42 Billion INR | -285.448% |
| Ajanta Pharma Limited | 46.38 Billion INR | 71.523% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -333.087% |
| Granules India Limited | 55.2 Billion INR | 76.075% |
| Medicamen Biotech Limited | 2.94 Billion INR | -348.482% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -226.414% |
| Piramal Enterprises Limited | 826.05 Billion INR | 98.401% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 91.23% |
| NATCO Pharma Limited | 69.06 Billion INR | 80.874% |
| Suven Life Sciences Limited | 2.84 Billion INR | -363.625% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -641.34% |
| Strides Pharma Science Limited | 58.39 Billion INR | 77.381% |
| Indoco Remedies Limited | 21.44 Billion INR | 38.413% |
| Alpa Laboratories Limited | 1.82 Billion INR | -623.288% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -775.517% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -156.462% |